miRInform® Thyroid

thyroid cancer diagnosis

miRInform® Thyroid

Effective August 13, 2014, Interpace Diagnostics™, LLC, a subsidiary of PDI, Inc. (NASDAQ:PDII), has acquired the miRInform® Thyroid Test from Asuragen, Inc.

An orderly transition of account management and customer support has been established, ensuring no disruption in Test availability. Current procedures and contact information will remain the same during the 90-day transition process.

During the transition period, the miRInform Thyroid Test will continue to be performed and supported within the Asuragen CLIA-certified and CAP-accredited laboratory. By the end of the transition period, Interpace Diagnostics will be fully supporting and performing the Test within their own CLIA-certified and CAP-accredited laboratory.

To find out more about the miRInform® Thyroid Test, please go to the Interpace Diagnostics website at www.interpacediagnostics.com